Protalix Biotherapeutics Inc (PLX)
Gross Profit Growth
56.54%
TTM · Period ending:
PLX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported56.54%period ending
Latest reported56.54%period ending
PLX TTM Gross Profit YoY % (206.57% → 56.54%)
Year-over-year change
High-resolution chart · PNG
PLX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 56.5424% | |
| 78.9299% | |
| -11.4477% | |
| 117.2426% | |
| 191.0093% | |
| -19.6151% | |
| -31.5958% | |
| -65.2287% | |
| -74.8846% | |
| 51.6654% | |
| 51.5795% | |
| 72.9974% | |
| 71.2705% | |
| -3.9181% | |
| 27.476% | |
| -18.3427% | |
| -13.5049% | |
| -36.8261% | |
| -57.7107% | |
| -33.4351% | |
| -38.1455% | |
| -24.7352% | |
| 18.784% | |
| -6.771% | |
| 0.2034% | |
| 23.6288% | |
| 19.634% | |
| 320.2503% | |
| 1,287.6143% | |
| 796.3629% | |
| 812.74% | |
| 296.4341% | |
| 74.9886% | |
| 234.6473% | |
| 400.7491% | |
| 172.1799% | |
| 257.3381% | |
| 487.6676% | |
| -9.0806% | |
| -176.6644% | |
| -132.8062% | |
| -108.8662% | |
| -85.5739% | |
| -0.7155% | |
| -26.0945% | |
| -34.2451% | |
| 0.3615% | |
| 9.0065% | |
| -13.6076% | |
| -76.9225% | |
| -77.5751% | |
| -81.1443% | |
| -74.6843% | |
| 591.1992% | |
| 297.5824% | |
| 4,589.491% | |
| 1,178.0595% | |
| 56.6797% | |
| 476.0331% | |
| -33.8043% | |
| 271.0592% | |
| 209.4017% | |
| 43.0499% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -100% | |
| -99.269% | |
| -99.2527% | |
| -94.4333% | |
| -83.1823% | |
| -17.7865% | |
| 206.5709% |